In a Proactive StockTube interview, Nicolas Serandour, chief operating officer (COO) and chief finance officer (CFO) Advanced Oncotherapy (AVO), says the firm is looking at “disrupting the market” with its proton cancer treatment technology.
In a Proactive StockTube interview, Nicolas Serandour, chief operating officer (COO) and chief finance officer (CFO) Advanced Oncotherapy (AVO), says the firm is looking at “disrupting the market” with its proton cancer treatment technology.